Epsilon M&A Deal Report - ObvieLine Laboratories
Transaction Multiples for the Valuation of Private Companies
Sinclair IS Pharma / ObvieLine Laboratories
No EMAT :
78446
Announced Date :
03/01/2014
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Sinclair IS Pharma
Target :
ObvieLine Laboratories
Country :
France
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Biomedical Research Laboratory
Business Description :
Founded in 2005, ObvieLine Laboratories engages in researching, developing, manufacturing, and distributing hyaluronic acid derma fillers. > Offers its products for filling wrinkles and augment...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|||||
| Current |
|
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biomedical Research Laboratory » = 34
| Date | Acquirer | Target | Country | Multiples | See details |
| 04/06/2015 | Addtech | Mediplast | Sweden | *** | 78240 |
| 08/06/2015 | Iberica de Mantenimiento (Iberman) | Iberdata Equipamentos | Portugal | * | 78228 |
Source: Epsilon Research / EMAT
